Evaluating heart imaging techniques for coronary disease treatment
Official title: Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial: Ischemia-guided Revascularization Using Perfusion Coronary CT vs. Fractional Flow Reserve
Run by Asan Medical Center · NCT02208388 · Data updated 2026-11-12
This study is testing whether using a specific heart imaging technique called computed tomography perfusion can help people with coronary artery disease get better treatment results compared to another method called fractional flow reserve.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Asan Medical Center Academic / other |
| Locations | 7 sites (Seoul, Songpa-Gu and 6 other locations) |
| Status | Recruiting |
| Started | August 12, 2014 |
| Main results expected | March 5, 2028 |
| Study ends | March 5, 2028 |
| Registry record updated | April 5, 2023 |
| Trial ID | NCT02208388 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 20 and older with diagnosed angina or equivalent symptoms and significant coronary artery stenosis.
✕Probably not a fit
Patients requiring surgical procedures or those with severe heart conditions or other significant health issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the safety and effectiveness of computed tomography perfusion (CTP) guided revascularization compared to fractional flow reserve (FFR) guided revascularization in patients with coronary artery disease. Participants will be evaluated based on their symptoms and the severity of their coronary artery blockages. The study will include patients aged 20 and older who meet specific criteria related to their heart condition and will exclude those with certain severe health issues. The goal is to determine which imaging technique provides better outcomes for patients undergoing treatment.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for patients with coronary artery disease, enhancing their recovery and quality of life.
How similar studies have gone: Previous studies have shown promising results with similar imaging techniques in guiding coronary interventions, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 20 and more * Diagnosed angina or angina equivalent symptom or positive exercise treadmill test * Patients with intermediate- or high-risk probability of CAD defined by Diamond and Forester * 70 % stenosis or more in coronary CTA * Willing to provide informed, written consent Exclusion Criteria: * Requirement for surgical procedure * Cardiogenic shock and/or need for mechanical/pharmacologic hemodynamic support * Recent STEMI (\<5 days) * Non STEMI, if the cardiac troponin is not stable or starting to decline * Left ventricular ejection fraction \<30% * Life expectancy \<2 years * Impaired renal function with an effective glomerular filtration rate less than 30mL/min/1.73 ㎡ or creatinine more than 2.0 mg/dL * Undergoing evaluation for organ transplantation * Participation or planned participation in another cardiovascular clinical trial * Pregnancy * Inability to take dual antiplatelet therapy for six months * Previous CABG * Left main disease requiring revascularization * Any target lesion with in-stent restenosis * NYHA class 3 or 4a * Severe and persistent angina with severe limitation in everyday living activities (Canadian Cardiovascular Society grading Class IV)
Where it's running
-
Asan Medical Center
Seoul, Songpa-Gu, South Korea Recruiting -
Hallym University Sacred Heart Hospital
Anyang, South Korea Completed -
Gangwon National Univ. Hospital
Chuncheon, South Korea Completed -
Keimyung University Dongsan Medical Center
Daegu, South Korea Completed -
Pusan National University Hospital
Pusan, South Korea Enrolling by invitation -
Pusan National University Yangsan Hospital
Pusan, South Korea Completed
Show 1 more location
-
Severance Hospital
Seoul, South Korea Withdrawn
Study contacts
- Principal investigator: Byoung-Wook Choi, MD — Severance Hospital
- Study coordinator: Young-Hak Kim, MD
- Email: mdyhkim@amc.seoul.kr
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
Predicting how coronary artery disease progresses in adults 45 and younger
This project will try to build prediction models using coronary CT scans and health data from people aged 18–45 to see who is more likely to have plaque get worse over time.
-
Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions
This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.
-
Italian Cardiac Rehabilitation Registry for Coronary Disease and Heart Failure
This registry collects real-world information to see how cardiac rehabilitation programs work for adults recovering from coronary disease or heart failure across Italy.
-
Orbital atherectomy versus standard balloon strategy for calcified coronary bifurcation lesions
This study tests whether using orbital atherectomy before stenting helps adults with moderately or severely calcified coronary bifurcation lesions get better stent results than the standard balloon-first approach.
-
Healthy Nordic diet's effects on heart disease
This study is testing if following a Healthy Nordic diet can help people with coronary heart disease improve their heart health over 18 months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.